Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 390, 335-336 (27 November 1997) | doi:10.1038/36978
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Regional Sales Manager- Genrric Division (Copporate Office)
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Senior Faculty Positions
- Torrey Pines Institute for Molecular Studies
- Port St. Lucie, FL
A cancer therapy resistant to resistance
Robert S. Kerbel1
The relentless growth of tumours depends on a good blood supply, and thus on subverting host mechanisms for making blood vessels. Attack on that process provides a promising route for treating cancer, but one that may take some years to reach clinical fruition.
-
Robert S. Kerbel is at the University of Toronto, and in the Cancer Research Program, Sunnybrook Health Science Centre, Research Building S-218, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5.
e-mail: Email: kerbel@srcl.sunnybrook.utoronto.ca
To read this story in full you will need to login or make a payment (see right).
